BIOMARIN PHARMACEUTICALBIOMARIN PHARMACEUTICALBIOMARIN PHARMACEUTICAL

BIOMARIN PHARMACEUTICAL

No trades
See on Supercharts

Price target

1,980.740.000.00%
The 25 analysts offering 1 year price forecasts for BMRN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 30 analysts giving stock ratings to BMRN in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BMRN EPS for the last quarter is 10.84 MXN despite the estimation of 10.46 MXN. In the next quarter EPS is expected to reach 11.12 MXN. Track more of BIOMARIN PHARMACEUTICAL financials and stay on top of what is up with the company.
In the next quarter BIOMARIN PHARMACEUTICAL revenue is expected to reach ‪14.85 B‬ MXN. Check out BIOMARIN PHARMACEUTICAL revenue and earnings and make informed decisions.
According to analysts, BMRN price target is 1,980.74 MXN with a max estimate of 2,624.73 MXN and a min estimate of 1,343.36 MXN. Check if this forecast comes true in a year, meanwhile watch BIOMARIN PHARMACEUTICAL stock price chart and keep track of the current situation with BMRN news and stock market news.
We've gathered opinions of 30 analysts rating BMRN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.